Dr. Fleshner's clinical practice is in urologic oncology with research interests in prostate and bladder cancer.
A phase I pilot study of pre-operative radiotherapy for prostate cancer: Long-term toxicity and oncologic outcomes.
Int J Radiat Oncol Biol Phys. 2019 Jan 06;:
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Nat Genet. 2019 Jan 08;:
The Prostate Cancer Rehabilitation Clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy.
Curr Oncol. 2018 Dec;25(6):393-402
Germ Cell Testicular Tumors - Contemporary Diagnosis, Staging and Management of Localized and Advanced disease.
Urology. 2018 Dec 28;:
Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.
J Urol. 2019 Jan;201(1):113-119
The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.
Cancer. 2018 Dec 18;:
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance.
Prostate Cancer Prostatic Dis. 2018 Dec 12;:
Abiraterone Acetate for Nonmetastatic Castration-Resistant Prostate Cancer-The Forgotten Dance Partner?
JAMA Oncol. 2018 Nov 29;:
Clin Epigenetics. 2018 Nov 23;10(1):147
Nature. 2018 Nov 14;:
Martin Barkin Chair, Division of Urology, Department of Surgery, University of Toronto
Professor, Department of Surgery, University of Toronto